Vergoeding 2017-2021 voor ATC-subgroep J05AG : Niet-nucleoside reverse-transcriptaseremmers
- Raming voor de totale Zvw-populatie
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| J05AG01 Nevirapine (Viramune ®) | 4.919.800 | 2.800.700 | 1.756.900 | 1.508.600 | 1.064.500 |
| J05AG03 Efavirenz (Stocrin ®) | 618.020 | 514.910 | 424.690 | 370.120 | 348.820 |
| J05AG04 Etravirine (Intelence ®) | 856.290 | 720.070 | 598.070 | 498.550 | 423.330 |
| J05AG05 Rilpivirine (Edurant ®) | 289.980 | 313.950 | 295.320 | 270.420 | 392.320 |
| J05AG06 Doravirine (Pifeltro ®) | . | . | 14.082 | 272.610 | 504.150 |
| Totaal | 6.684.090 | 4.349.630 | 3.089.062 | 2.920.300 | 2.733.120 |